Optimizing clinical trial workflow: Elevating the role of the pharmacy technician within investigational drug services
NCODA Oncology and Hematology Meeting Abstracts · 13.10.2026 · 2 (2)
DOI: 10.67209/buux3423 ↗Kurz gefasst
Fachartikel in der Zeitschrift NCODA Oncology and Hematology Meeting Abstracts, online erschienen am 13.10.2026. Verfasst von Jannette Cruz Vallellanes und 1 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Background
The growing complexity of precision oncology, cellular therapies, and immunotherapies increases operational demands for investigational medicinal product management. At Moffitt Cancer Center, the investigational drug services (IDS) pharmacy supports approximately 300 active clinical trials and 450 sponsor monitoring visits annually.
Objective
Describe the roles and operational impact of pharmacy technicians within oncology IDS, including their contributions to regulatory compliance, audit readiness, workflow efficiency, and pharmacist resource allocation. Significance: A specialized IDS pharmacy technician role was developed to reduce pharmacist workload, remove workflow bottlenecks, and strengthen regulatory compliance. The IDS framework follows American Society of Health-System Pharmacists (ASHP) and Hematology/Oncology Pharmacy Association (HOPA) best-practice standards, International Council for Harmonisation Good Clinical Practice (ICH GCP), Food and Drug Administration (FDA), Title 21 of the Code of Federal Regulations (CFR), Part 312, institutional policies, and United States Pharmacopeia (USP) / requirements. Adaptability: Qualification is built on three pillars: (1) foundational didactic and regulatory education, including formal modules in GCP, Human Subjects Protection (Collaborative Institutional Training Initiative [CITI] Program), FDA 21 CFR Part 312, and the ASHP IDS Certificate; (2) operational and technical systems training, including hands-on instruction in Interactive Response Technology (IRT), electronic accountability software, cold-chain management, and blinded/unblinded product handling; and (3) supervised clinical practice and validation, including protocol-specific shadow training with senior staff, direct audit observations, and annual sterile/cellular admixture validations. Advanced technician responsibilities encompass five domains: (1) drug accountability and inventory oversight, including receiving investigational medicinal product (IMP) shipments, verifying lot numbers and expiration dates, maintaining drug accountability record forms (DARFs), managing stock, and coordinating return and destruction; (2) preparation and dispensing, including preparation of intravenous (IV) and oral investigational or hazardous agents under pharmacist oversight and within institutional scope according to USP /, verification of preparation accuracy, and maintenance of protocol-specific blinding requirements; (3) protocol and regulatory compliance, including maintaining GCP and Good Manufacturing Practice (GMP) compliance, monitoring storage and temperature parameters, and executing immediate cold-chain excursion quarantines; (4) study operations and sponsor relations, including facilitating monitor visits, assisting with audits and standard operating procedures (SOPs), tracking workload metrics, and resolving operational study issues; and (5) training and professional development, including orienting staff and trainees, validating competencies, and using credentials such as the ASHP IDS Certificate to advance practice standards. Before monitoring visits, technicians reconcile inventory, verify DARFs, and compile temperature logs. This preparation supports audit readiness, shorter monitor-query turnaround, fewer workflow interruptions, accurate inventory, reduced storage and handling deviations, and faster trial operationalization from activation to first patient dosing.
Conclusion
Specialized IDS pharmacy technicians strengthen clinical trial workflows, audit readiness, and compliance while allowing research pharmacists to practice at the top of their license. Future priorities include standardized national curricula, expanded certification, and technician-led quality-improvement pathways. Funding: Not Applicable.
Zitieren
APA
Vallellanes, J. C., & Moya, C. D. (2026). Optimizing clinical trial workflow: Elevating the role of the pharmacy technician within investigational drug services. NCODA Oncology and Hematology Meeting Abstracts, 2(2). https://doi.org/10.67209/buux3423
Vancouver
Vallellanes JC, Moya CD. Optimizing clinical trial workflow: Elevating the role of the pharmacy technician within investigational drug services. NCODA Oncology and Hematology Meeting Abstracts. 2026;2(2). doi:10.67209/buux3423
BibTeX
@article{Vallellanes2026,
author = {Vallellanes, Jannette Cruz and Moya, Carmen De},
title = {Optimizing clinical trial workflow: Elevating the role of the pharmacy technician within investigational drug services},
journal = {NCODA Oncology and Hematology Meeting Abstracts},
year = {2026},
volume = {2},
number = {2},
doi = {10.67209/buux3423}
}
EUVIMED